Author:
DiFrancesco Lisa M,Murthy Sabita K,Luider Joanne,Demetrick Douglas J
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference47 articles.
1. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, et al. Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 1998; 16 (4): 1340–9.
2. Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK . Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer. Anticancer Res 1997; 17 (4B): 3091–7.
3. Tsuda H, Sakamaki C, Tsugane S, Fukutomi T, Hirohashi S . A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases. Breast Cancer Res Treat 1998; 48 (1): 21–32.
4. Ross JS, Sheehan C, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman R, et al. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization. Hum Pathol 1997; 28 (7): 827–33.
5. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, et al. Correlation of c-erb-B2 amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1988; 48: 1238.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献